Tyrosinase (56-70)
Need Assistance?
  • US & Canada:
    +
  • UK: +

Tyrosinase (56-70)

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

A peptide fragment of Tyrosinase. Tyrosinase is a rate-limiting enzyme for controlling the production of melanin. It is found inside melanosomes which are synthesized in the skin melanocytes. In humans, the tyrosinase enzyme is encoded by the TYR gene.

Category
Others
Catalog number
BAT-009906
Sequence
QNILLSNAPLGPQFP
Storage
Common storage 2-8°C, long time storage -20°C.
1. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes
S L Topalian, M I Gonzales, M Parkhurst, Y F Li, S Southwood, A Sette, S A Rosenberg, P F Robbins J Exp Med. 1996 May 1;183(5):1965-71. doi: 10.1084/jem.183.5.1965.
Tyrosinase was the first melanoma-associated antigen shown to be recognized by CD4+ T cells. In this study, we have identified two HLA-DRB1*0401-restricted peptides recognized by these T cells: Ty 56-70 and Ty 448-462. As with many of the MHC class I-restricted melanoma epitopes, both are nonmutated self peptides that have intermediate and weak MHC binding affinities, respectively. Mutated and truncated versions of these peptides were used to define their MHC binding anchor residues. Anchor residues were then modified to derive peptides with increased MHC binding affinities and T cell stimulatory properties. Ty 56-70 and Ty 448-462 enhance the list of immunogenic HLA-A2-, A24-, and B44-restricted tyrosinase peptides already described. Thus, tyrosinase provides a model for anti-melanoma vaccines in which a single molecule can generate multivalent immunization incorporating both CD4+ and CD8+ T cell responses.
2. Repigmentation of cutaneous scars depends on original wound type
Sarah L Chadwick, Christina Yip, Mark W J Ferguson, Mamta Shah J Anat. 2013 Jul;223(1):74-82. doi: 10.1111/joa.12052. Epub 2013 May 14.
Cutaneous scarring is currently an inevitable outcome following skin injury. Abnormal pigmentation within scars makes them more noticeable, causing distress for patients, particularly as there is no reliable and effective treatment available to date. The Duroc pig, known to scar badly, was used to investigate repigmentation of scars resulting from three different wound types: incisional, partial thickness excisional and full thickness excisional. Wounds were created on the backs of Duroc pigs and the resulting scars harvested at days 35, 56, 70 and 90 days post-injury. Scars were processed for histology and immunohistochemistry, quantitatively analysed using image analysis software and subjected to statistical analysis. Photographs of the macroscopic appearance of scars were scored for pigmentation using a visual analogue scale. Results demonstrated temporal and spatial differences in melanocyte repopulation and function within scars from different wound types. The microscopic pigment deposition did not correlate with macroscopic appearances in mature scars. Pigmentation of scars is dependent on the width and depth of wounds. This study has provided important information on which we can base future studies to investigate factors controlling the repigmentation of scars.
Online Inquiry
Verification code
Inquiry Basket